Furthermore, consistent with the observation that AURKA is required for growth of MYCN amplified neuroblastoma, cells expressing high levels of MYCN were more sensitive to CCT137690 in comparison to cells expressing low or no MYCN (Faisal et al., 2011). This evidence concerns the gene AURKA and neuroblastoma.